We studied monocytic differentiation of primary mouse progenitor cells to understand molecular mechanisms of differentiation. We found a tightly controlled non-apoptotic activation of caspase-3 that correlated with differentiation. Although caspase activity was already detected during monocytic differentiation, a caspase-3 target has not been identified yet. We show that hematopoietic progenitor kinase 1 (HPK1) is processed towards its N-and C-terminal fragments during monocytic differentiation. While HPK1 is an immunoreceptor-proximal kinase in T and B cells, its role in myeloid cells is elusive. Here, we show that the N-terminal cleavage product, HPK1-N, comprising the kinase domain, confers progenitor cell survival independent of the growth factor IL-3. Furthermore, HPK1-N causes differentiation of progenitor cells towards the monocytic lineage. In contrast to full-length kinase, HPK1-N is constitutively active causing sustained JNK activation, Bad phosphorylation and survival. Blocking of caspase activity during differentiation of primary mouse progenitor cells leads to reduced HPK1-N levels, suppressed JNK activity and attenuated monocytic differentiation. Our work explains growth factor-independent survival during monocytic differentiation by caspase-mediated processing of HPK1 towards HPK1-N. Cell Death and Differentiation (2007) 14, 568-575. doi:10.1038/sj.cdd.4402042; published online 6 October 2006
Within the hematopoietic system lineage commitment, differentiation and proliferation are precisely balanced throughout life, resulting in adjusted levels of myeloid and lymphoid cells. A complicated network of cytokines essentially contributes to hematopoietic homeostasis. Myeloid progenitor cells and myeloid-like cell lines respond to the cytokine interleukine-3 (IL-3) with proliferation and survival. 1 While removal of IL-3 results in cell death via apoptosis, suppression of apoptosis allows differentiation of the mouse hematopoietic progenitor cell line FDC-P1 in the absence of IL-3. 2 Monocytic differentiation of primary bone marrow and fetal liver progenitors or myeloid cell lines can be induced by IL-3 withdrawal and stimulation with monocyte-colony stimulating factor (M-CSF). 3 Monocytic differentiation is accompanied by caspase activation; 4, 5 however, the molecular targets of caspase activity during monocytic differentiation have not been identified.
Hematopoietic progenitor kinase 1 (HPK1) is comprised of a catalytic domain with extensive homology to the Sterile 20 kinase of the yeast Saccharomyces cerevisiae and a Cterminally located regulatory domain, called citron homology domain. 6 Ectopic expression renders full-length HPK1 active in epithelial cells resulting in selective activation of the JNK and the NFkB pathways. 7, 8 Upon caspase-3 cleavage the N-terminal kinase domain of HPK1 (HPK1-N) is separated from the C-terminus (HPK1-C) resulting in suppression of NFkB. 8 In non-stimulated lymphocytes, HPK1 kinase activity is hardly detectable, but antigen receptor crosslinking leads to profound HPK1 activation. 9, 10 HPK1 activation involves binding of cell-specific adaptor proteins, relocation to the plasma membrane, autophosphorylation and transphosphorylation by protein kinase D1. [11] [12] [13] While a role for HPK1 in the regulation of T-cell apoptosis was already suggested, 14 our recent studies have shown proteolytic processing of HPK1 into HPK1-C in non-apoptotic preactivated primary T cells. 15 In this study, the cleavage product HPK1-C sensitizes towards T-cell receptor-mediated cell death, while full-length HPK1 enables activation and survival of T cells. In contrast to the studies in lymphoid cells, which suggest that HPK1 acts as a life/death switch, relatively little is known about the role of HPK1 in myeloid cells.
Here we show a tightly controlled, non-apoptotic activation of caspase-3 during monocytic differentiation of primary mouse progenitor cells that correlates with proteolytic processing of HPK1. The presence of HPK1-N results in cytokine-independent survival of FDC-P1 myeloid progenitor cells and upregulation of markers for monocytic differentiation. While kinase activity of full-length HPK1 depends on IL-3 stimulation in FDC-P1 cells, HPK1-N is a constitutive active kinase causing sustained JNK activity. Thereby, apoptosis of HPK1-N bearing cells is prevented by phosphorylation of Bad and differentiation can proceed. Our work suggests HPK1 to be a molecular target of caspase-3 activity during monocytic differentiation.
Results
Activation of caspase-3 during monocytic differentiation of primary mouse progenitor cells. We induced in vitro differentiation of primary mouse progenitor cells to better understand the molecular mechanisms underlying monocytic differentiation (Figure 1a) . Unfractionated mouse bone marrow or fetal liver cells were used as starting population. During a 48-h preculture period, monocytic progenitors remained in suspension and were subsequently separated from differentiated adherent cells. Remaining progenitor cells were further differentiated after removal of IL-3 for 7 days in the presence of M-CSF. During this in vitro differentiation the percentage of cells staining positive for the differentiation markers F4/80 and Mac-1 (CD11b) constantly increased ( Figure 1b) . By day 9 most of the cells displayed a macrophage-like morphology and were adherent to the cell culture dish (data not shown). During this period the level of apoptotic cells in our in vitro differentiation system staining positive for annexin V (Anx V) remained rather constant (Figure 1b) . In contrast, we detected the temporally tightly controlled appearance of the active p17/p19 fragments of caspase-3 around days 3-6 (Figure 1c) , suggesting a nonapoptotic caspase activity during monocytic differentiation, which has been previously reported. 4, 5 Accordingly, application of the caspase inhibitor z-VAD-fmk during in vitro culture of progenitor cells blocks monocytic differentiation. 4 However, a caspase-3 target involved in monocytic differentiation has not been identified yet.
HPK1 is a caspase-3 substrate during monocytic differentiation. In search of caspase-3 substrates, which are cleaved during in vitro differentiation of primary mouse progenitors, we found HPK1 to be processed into its N-and C-terminal fragments (Figure 1d ). Accumulation of the HPK1 cleavage products at days 5 and 6 of differentiation is seen just after peaking of active caspase-3 at day 4. Therefore, endogenous HPK1 might be a target of active caspase-3 during monocytic differentiation in vitro. In contrast, we did not find any cleavage of the apoptosis-related caspase-3 target PARP (data not shown). This result further strengthens a non-apoptotic role for caspase-3 during monocytic differentiation, which is supported by the absence of significant apoptosis during our in vitro culture (Figure 1b) . Therefore, our data suggest that cleavage of HPK1 by caspase-3 is implicated in monocytic differentiation.
IL-3 independent survival of progenitor cells harboring HPK1-N. To further analyze the role of the HPK1 cleavage fragments, we took advantage of the mouse myeloid progenitor cell line FDC-P1 16 and using retroviral transduction generated cell clones stably expressing either HPK1-N or HPK1-C (Figure 2a ). Five clones (N-1 to N-5 and C-1 to C-5, respectively) were pooled for subsequent analysis to avoid effects of clonal variation and compared to pooled clones containing the virus without insert (vector). While the HPK1-N expressing cell pool displayed a slightly delayed proliferation rate (Figure 2b) , the presence of HPK1-N did not influence viability of FDC-P1 cells in the presence of IL-3 ( Figure 2c ).
Growth and survival of the hematopoietic progenitor cell line FDC-P1 is strictly IL-3 dependent 2 and apoptosis can be induced by IL-3 withdrawal. Therefore, we subjected the pooled HPK1-N and HPK1-C cell clones to IL-3 deprivation, resembling the shortage of this growth factor in the in vitro differentiation system applied ( Figure 1a , days 3-9). Interestingly, the HPK1-N cell pool was largely resistant towards apoptosis-induction by IL-3 withdrawal (Figure 2c ). In contrast, the HPK1-C expressing cells mildly increased the sensitivity towards cell death, which was also seen previously in lymphocytes. 15 Prolonged culture of HPK1-N cells without IL-3 also significantly decreased viability (Figure 2d ). This result shows that HPK1-N cells are largely apoptosisresistant, but not completely IL-3 independent, a state that would likely require additional factors. Testing this idea, we found that the addition of macrophage-colony stimulating factor (M-CSF) increased survival of HPK1-N cells. While vector transduced FDC-P1 cells did not respond to this cytokine (Figure 2d ), FDC-P1 cells do not express the receptor for M-CSF (M-CSFR) and can only be rendered responsive to M-CSF by differentiation induction or by ectopic expression of the M-CSFR. 20 Therefore, it was likely that the presence of HPK1-N induced the expression of M-CSFR. To address the question, whether the adherence of HPK1-N cells might influence their susceptibility towards apoptosis, suspended cells were collected and adherent cells were released from the Petridish by pipetting, deprived of IL3 and reseeded. After 18 h the rate of apoptosis was significantly higher in cells previously growing in suspension (data not shown). This again suggests that cytokine-independent survival of HPK1-N cells is linked to the adherence-phenotype and thereby to ongoing differentiation of these cells.
To examine the presence of the monocytic differentiation markers M-CSFR or Mac-1 (CD11b) in HPK1-N cells, we used RT-PCR. Addition of M-CSF rescued HPK1-N cells from apoptosis after IL-3 withdrawal (Figure 2d ) and we detected expression of M-CSFR message in HPK1-N cells at similar levels as in in vitro generated primary monocytes (Figure 3c ). In addition, HPK1-N cells were also positive for the differentiation marker Mac-1. FDC-P1 cells containing empty vector or elevated expression of HPK1 8 did not show Mac-1 expression (Figure 3c ). Furthermore, HPK1-N cells stained positive for the differentiation marker F4/80 (data not shown). These results further support our hypothesis that HPK1-N drives FDC-P1 cells towards monocytic differentiation.
Finally, we tested for functional monocytic differentiation and found HPK1-N cells capable of enhanced phagocytosis compared to vector control cells (Figure 3d ). This result shows that HPK1-N cells have acquired functional properties typical of the monocytic lineage and suggests a biological role for HPK1-N in mediating monocytic differentiation of progenitor cells.
Antiapoptotic Bad phosphorylation and sustained JNK activation by HPK1-N. To understand the role of HPK1-N during myeloid differentiation on the molecular level, we next analyzed affected signaling pathways. Activation of the JNK pathway is known to mediate IL-3 dependent survival of the hematopoietic progenitor cell line FDC-P1. 23 In addition, JNK activity has been reported to be necessary for myeloid differentiation. 24 Therefore, we first analyzed the kinase activity of endogenous JNK proteins in HPK1-N cells compared to stable FDC-P1 cell pools containing HPK1-C or empty vector (Figure 4a ). We found that already under normal growth conditions HPK1-N cells showed a robust four-fold elevation of JNK activity, while in HPK1-C cells JNK activity was only slightly enhanced. This observation was also made in previous studies showing robust JNK activation by ectopic expression of the liberated kinase domain of HPK1 in epithelial cells. 8, 25 Furthermore, this result suggests that survival and differentiation of HPK1-N cells might be linked to activation of the JNK pathway. To test whether there is a link between JNK activation and survival of HPK1-N cells without IL-3, we compared the JNK activity of adherent HPK1-N cells and HPK1-N cells growing in suspension. Interestingly, we found a higher constitutive JNK activity in adherent HPK1-N cells (Figure 4b ). This correlated with the higher apoptosis-resistance of these cells. This result again points towards a role for sustained JNK activation in cytokine-independent survival of HPK1-N cells.
In hematopoietic progenitor cells, JNK activity is dependent on IL-3 stimulation. 23 To test, if IL-3 treatment might also induce JNK activity in HPK1-N cells, we deprived the cells from IL-3 and tested phosphorylation of endogenous JNK proteins following readdition of IL-3. While JNK signaling was induced by IL-3 in FDC-P1 cells containing empty vector, HPK1-N cells displayed JNK activity already without IL-3 stimulation (Figure 4c, top panel) . In addition, the JNK target Bad 23 remained phosphorylated in HPK1-N cells in the absence of IL-3 stimulation (Figure 4c, bottom panel) . These results provide a first explanation for the cytokine-independent survival of HPK1-N cells by antiapoptotic phosphorylation and subsequent sequestration of Bad partly due to sustained JNK activation.
Sustained JNK activation by constitutive kinase activity of HPK1-N. To better understand the role of endogenous HPK1 and HPK1-N as upstream activators of the JNK pathway, 7, 8 we precipitated both HPK1 proteins from IL-3 stimulated or non-stimulated cells and determined their activity by an in vitro kinase assay. As expected, the kinase activity of endogenous full-length HPK1 was found to be IL-3 dependent (Figure 4d, top panel) . In contrast, HPK1-N kinase activity was independent of IL-3 and not further enhanced by addition of cytokine (Figure 4d , middle panel). Our results indicated that in myeloid cells HPK1-N is a constitutive active kinase, while activity of full-length HPK1 is controlled by IL-3. Thereby, deregulated and persistent HPK1-N kinase activity provides an explanation for sustained JNK activation in the absence of IL-3 and a molecular mechanism for myeloid progenitor cell survival during growth factor deprivation and monocytic differentiation.
Blocking of caspase activity reduces monocytic differentiation. To test if caspase activity is required for monocytic differentiation, we applied the pan-specific caspase inhibitor z-QVD-fmk to our in vitro differentiation system following the 2-day preculture period. On day 4 of differentiation, the addition of QVD had effectively reduced the accumulation of processed caspase-3 (Figure 5a ), which was found to be most prominent at this time point before (Figure 1c) . Consequently, addition of the caspase inhibitor led to a reduction of HPK1 processing towards HPK1-N (Figure 5b, top panel) , indicating that HPK1 is cleaved by caspases during in vitro differentiation. Furthermore, HPK1-N kinase activity (Figure 5b , middle panel) and total JNK activity (Figure 5b , bottom panel) were found to be reduced, indicating that HPK1-N activity contributes to JNK activation in primary mouse progenitor cells during differentiation.
Most strikingly, the presence of the caspase inhibitor z-QVD-fmk caused a reduction in the number of differentiating cells in vitro (Figure 5c ). This reduced differentiation was not due to increased apoptosis as nuclear fragmentation was nearly absent in the presence of z-QVD-fmk (Figure 5d ). Therefore, HPK1-N kinase activity and sustained JNK activation in the absence of IL-3 are likely regulated by caspase activity and crucial for monocytic differentiation.
Discussion
We studied myeloid cell differentiation towards the monocytic lineage in vitro to gain a better understanding of the mechanisms of differentiation. We detected a tightly controlled non-apoptotic caspase-3 activity during differentiation of primary mouse progenitor cells resulting in cleavage of HPK1. The N-terminal fragment, HPK1-N, comprising the isolated kinase domain, was shown to mediate robust cytokine-independent JNK activation in FDC-P1 hematopoietic progenitor cells. Consequently, constitutive HPK1-N kinase activity led to sustained JNK activity and induced phosphorylation of Bad. Over the last years evidence for cell-autonomous hematopoietic lineage decisions has accumulated and it appears necessary to prevent apoptosis in order to allow for differentiation of progenitor cells. 2 Here, we provide an example, how the isolated kinase domain of HPK1, HPK1-N, can contribute to monocytic differentiation of hematopoietic progenitor cells by eliciting stimulation-independent JNK activation. This mechanism may contribute to the switch from IL-3 dependent towards IL-3 independent survival during differentiation of primary progenitor cells. Nevertheless, the differentiation of FDC-P1 progenitor cells harboring HPK1-N does not proceed to a final stage of complete IL-3 independent survival (Figure 2d) . Furthermore, complementation of HPK1-N cells with the C-terminal HPK1 fragment, HPK1-C, did also not lead to a complete release from cytokine-dependency (data not shown). This clearly indicates that differentiation of progenitor cells does not depend on singular activation of one pathway or protein. In addition to JNK-dependent mechanisms, PKCa has been shown to suppress apoptosis induced by IL-3 withdrawal 26 and Akt protein kinase was found to mediate IL-3 dependent survival. 27 Cell survival during differentiation may involve upregulation of antiapoptotic proteins like Bcl-X L and XIAP. 28 While HPK1-N cells already react to M-CSF stimulation (Figure 2d ) and express the M-CSFR (Figure 3c ), M-CSFR triggered pathways may function inefficiently. 20, 29, 30 Caspase cleavage of HPK1 was shown to modulate its function in lymphocytes. 8, 14 In contrast, little is known about the role of HPK1 in myeloid cells. Our report indicates that caspase-mediated cleavage may be a general feature of HPK1 signal transduction. Depending on the cell type, caspase cleavage might uncouple HPK1 activity from antigen-receptor or cytokine-receptor signaling. In lymphocytes, HPK1 cleavage leads to inefficient T-cell receptor stimulation and results in apoptosis-sensitivity. 15 In myeloid progenitor cells cleaved HPK1 results in constitutive cytokineindependent signaling and enables prolonged cell survival. Similar to our finding, the potential to mediate differentiation of lymphoid and myeloid progenitors has also been shown for constitutively active b-catenin. 31 Accumulating evidence suggests that caspases are not exclusively involved in cell death programs, but rather fulfill various important tasks in non-apoptotic processes. While the non-apoptotic functions for caspases might be dependent on the cell type they are often linked to developmental programs, such as keratinocyte differentiation. 32 Commitment to terminal keratinocyte differentiation was reported to be mediated by a caspase-3 dependent inactivation of PKCd. 33 Further examples for non-apoptotic caspase activities include erythrocyte differentiation, 34 platelet formation 35 or T-cell activation and proliferation. 36, 37 A caspase-like activity was also found to be required for survival of dendritic cells and control of dendritic cell maturation. 8, 38, 39 Albeit for myeloid cells the involvement of caspases in monocytic differentiation is most evident, 4,5 the functional role of the caspase targets recently identified during differentiation of progenitor cell lines is elusive. 40 Therefore, cleavage of full-length HPK1 in primary myeloid progenitor cells and the generation of a constitutively active HPK1-N kinase provide a possible mechanistic explanation for growth factor-independent survival during monocytic differentiation. Functional analyses of additional caspase targets will probably further improve the understanding of monocytic differentiation in the future.
Materials and Methods
Primary cell culture and generation of stable FDC-P1 cell lines. Total mouse bone marrow or total mouse fetal liver cells were used as starting population for in vitro differentiation. Bone marrow was prepared by syringemediated flushing of marrow-rich bones (e.g. femur, tibia) with cell culture medium. To generate a cell suspension, mouse fetal liver was passed through a nylon mesh (BD Falcon, Cell Strainer 70mM). Harvested bone marrow or fetal liver cells were washed with cell culture medium and resuspended in ACK buffer (150 mM NH 4 Cl, 10 mM KHCO 3 , 1 mM Na 2 EDTA, pH ¼ 7.3) and incubated for 5 min to lyse erythrocytes. After additional washing, harvested cells were reseeded in cell culture medium and cultivated for 2 days in the presence of IL-3 and M-CSF to enrich for myeloid progenitors. During this preculture period, fibroblast-like cells and predifferentiated monocytic cells adhered to the cell culture dish, while monocytic progenitors remained in suspension. Suspension cells were harvested, IL-3 was removed from the cell culture medium and cells were differentiated for an additional 7 days in cell culture medium supplemented with M-CSF. Primary mouse progenitor cells and the IL-3 dependent mouse hematopoietic progenitor cell line FDC-P1 16 were cultured in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 5% fetal bovine serum (Sigma), 100 mg/ml penicillin (Life Technologies), 100 mg/ml streptomycin (Life Technologies), 20 mM L-glutamine (Life Technologies), 0.001% monothioglycerol (Sigma) and 1.5% conditioned medium of the myeloma cell line X63 Ag8-653 IL-3 as a source of IL-3. 17 During culture of primary mouse progenitor cells, 10% conditioned medium of the cell line L929 was added as a source of M-CSF. The caspase inhibitor QVD (Imgenex) was dissolved at 10 mM in DMSO and used at a final concentration of 5 mM. FDC-P1 cells were infected using transient supernatants of the ecotropic packaging cell line GP þ E 86 transfected with 10 mg of empty retroviral vector or vector encoding fulllength HPK1, HPK1-N (aa 1-328) or HPK1-C (aa 271-827), respectively. At 48 h later, selection with 1 mg/ml G418 (Gibco/BRL) was applied for 12 days.
In vitro kinase assays, SAPK activation and western blotting. HPK1 and JNK kinase assays were performed as described before. 7 Briefly, 10 7 cell were lysed in 1 ml of buffer A (50 mM Tris/HCl, pH ¼ 8.0, 120 mM NaCl, 1% (v/v) NP-40, 200 mM Na 3 VO 4 , 5 mM DTT, 25 mM NaF, 1 mM PMSF) and antibodies directed against JNK1/2 (Santa Cruz and Abcam, 10 ml each) or HPK1 (rabbit sera no. 5/6, reacting with native full-length HPK1, 20 ml) or HPK1-N (rabbit sera no.9/10, reacting with the native HPK1 N-terminus, 20 ml) were used to immunoprecipitate kinase active proteins. After washing with buffer A, the precipitate was incubated in kinase buffer (50 mM Tris/HCl (pH ¼ 8.0), 2 mM MnCl 2 , 5 mM MgCl 2 , 0.5 mM DTT) with 5 mCi 32 P-g-ATP and GST:c-Jun N as substrate for 20 min at 301C. Phosphorylated proteins were resolved by SDS-PAGE and exposed to X-ray film (Hyperfilm, Amersham). Polyclonal rabbit sera anti-HPK1 for Western blotting (no. 2 raised against HPK1 N-terminus or no. 7 raised against HPK1 C-terminus) have been described previously. 7, 8 The antibodies used were: anti-caspase-3 (R&D Systems), anti-JNK (Santa Cruz and Abcam), anti-phospho-JNK (Cell Signaling Technology), anti-Bad (Santa Cruz), anti-phospho-Bad (Cell Signaling Technology).
Apoptosis, phagocytosis and cell staining. To quantify apoptotic FDC-P1 cells we determined the sub-G1 fraction by flow cytometry. Cells were collected, washed with PBS and fixed by slow application of 4 volumes 70% (v/v) Ethanol for 30 min on ice. After washing with PBS fixed cells were incubated with propidium iodide (PI)-staining solution (20 mg/ml popidium idodide, 200 mg/ml RNase A in PBS) for 30 min at room temperature. Subsequent analysis was performed using a FACscan (Beckton Dickinson). Apoptotic mouse progenitor cells were detected by Annexin V staining or PI-staining. 18 For analysis of phagocytosis, cells were incubated with yellow-green FluoSpheres (Molecular Probes) for 4 h, washed extensively and analyzed by flow cytometry. For May-Grünwald-Giemsa staining FDC-P1 cells were spread on glass slides by cytocentrifugation, air-dried, methanol fixed and stained.
Reverse transcriptase polymerase chain reaction (RT-PCR) analysis. Following reverse transcription PCR reactions of Trizol-purified (Invitrogen) RNA were performed as described. 19 The following oligonucleotides were used: myeloperoxidase (MPO), cgcttctccttcttcactgg and ctgccattgtcttggaatcg; MCSFR (c-fms), agcttggcccgactctgacacttc and ttggagaggagcacacggtttttg; Mac-1 (CD11b), gagcctccctgtcagtgtagtctt and gggggcagcttcattcatc.
